Dr. Gilotra and Dr. Lin were each awarded $100k through FSR’s Cardiac Sarcoidosis Grant program, and Dr. Kahlmann and Dr.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michelle M.

Sarcoidosis is an inflammatory disease that can range from being asymptomatic to causing severe complications. It occurs when clusters of immune cells, known as granulomas, form in various organs, ...

ROCK ISLAND, Ill. — Today's health care landscape remains a challenge and one rare inflammatory disease causing a ripple effect is sarcoidosis. According to the American Lung Association, the United ...

The FSR-GSCA is a global network of leading sarcoidosis clinics and hospitals committed to advancing research, strengthening ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Background: The pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) influenced millions of lives, not only healthy subjects but also ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Rheumatologists may be the best clinicians to manage the challenges presented by sarcoidosis, which ...